期刊文献+

单项和联合指标在结节病诊断中的预测价值评价 被引量:3

Predictive value of single and combined indexes in the diagnosis of sarcoidosis
原文传递
导出
摘要 目的评价结节病诊断中各单项和联合诊断指标的预测价值。方法回顾性分析北京协和医院2001年1月至2007年9月间88例初步诊断为结节病的患者的临床资料,应用受试者工作特征曲线(ROC曲线)和Bayes方法对BALF细胞分类中的淋巴细胞比例、淋巴细胞亚群CD4/CD8、血清血管紧张素转换酶(ACE)等3项指标及其联合指标的诊断预测价值进行评价。采用ROC曲线评价各指标的诊断价值并确定指标的界定值,采用判别分析和ROC曲线评价联合指标的诊断价值。结果在88例初步诊断为结节病的患者中,经活检确诊结节病59例(67%),男性16例(27%),女性43例(73%),平均年龄(48±10)岁;排除结节病29例(33%),男性12例(41%),女性17例(59%),平均年龄(49±13)岁。单项指标淋巴细胞比例、CD4/CD8值和ACE的ROC曲线下面积分别为0.64、0.74和0.69,CD4/CD8值在3项指标中的诊断效率最高;通过ROC曲线的切点和坐标结合确定3项指标的最佳界定值是淋巴细胞比例≥30%,CD4/CD8值≥4.0,ACE≥40U/L;其阳性预测值分别为76.7%、80.4%和76.8%,表明CD4/CD8值在3项指标中的预测价值最高。CD4/CD8值和ACE联合指标的曲线下面积为0.81,CD4/CD8值、ACE、淋巴细胞比例3项联合指标的曲线下面积为0.78,均大于单项指标的曲线下面积,前者的诊断效率优于后者。CD4/CD8值和ACE并联指标的阳性预测值为83.9%,串联指标的阳性预测值为90.5%,明显高于单项指标的相同评价指标,表明将CD4/CD8值和ACE联合起来诊断结节病的效率和预测价值均高于各单项指标。结论BALF淋巴细胞亚群中CD4/CD8值仍然是辅助诊断结节病的有效单项指标,采用CD4/CD8值和ACE联合指标诊断结节病可提高诊断效率和预测价值。 Objective To evaluate the predictive value of single and combined indexes in the diagnosis of sarcoidosis. Methods Eighty-eight patients suspected of having sarcoidosis were retrospectively investigated. The diagnostic predictive value of lymphocyte percentage and CD4/CD8 ratio in bronchoalveolar lavage (BAL) , angiotensin converting enzyme (ACE) and their combination was evaluated by ROC curve method and Bayes' rule. Results Final diagnosis of sarcoidosis by biopsy was available in 59 patients (67%), 16 were males (27%), 43 were females (73%), with a mean age of (48 ±10) years. The diagnosis of non-sarcoidosis was available in 29 patients (33%) , 12 were males (41%) , 17 were females (59%) , with a mean age of (49 ± 13) years. The ROC curve area of lymphocyte percentage, CD4/CD8 ratio and ACE were 0. 64, 0. 74 and 0. 69 respectively; CD4/CD8 ratio had the best diagnostic efficiency. The optimized cut-offs of the three single indexes, lymphocyte percentage ≥30% , CD4/CD8 ratio ≥4. 0 and ACE≥40 U/L, were determined by the tangential points and coordinates of the ROC curve. The positive predictive values were 76. 7% , 80.4% and 76. 8% respectively; CD4/CD8 ratio had the best predictive value. The ROC curve area of the combined CD4/CD8 ratio and ACE was 0. 81, and the combination of lymphocyte percentage, CD4/CD8 ratio and ACE was 0. 78. They were both higher than those of the respective single indexes. The combination of CD4/CD8 ratio and ACE had the best diagnostic efficiency. On the other hand, it had the best positive predictive value of 90. 5% in all the diagnostic indexes. Conclusion CD4/CD8 ratio in BAL is still a useful index in the auxiliary diagnosis of sarcoidosis. The combination of CD4/CD8 ratio and ACE can improve the diagnostic efficiency and predictive value of sarcoidosis.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2008年第7期488-491,共4页 Chinese Journal of Tuberculosis and Respiratory Diseases
关键词 结节病 肽基二肽酶A 支气管肺泡灌洗液 淋巴细胞 Sarcoidosis Peptidyl-dipeptidase A Bronchoalveolar lavage fluid Lymphocytes
  • 相关文献

参考文献11

  • 1Statement on sarcoidosis. Am J Respir Crit Care Med, 1999,160: 736-755.
  • 2Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Eur Respir J,1999,14 : 735-737.
  • 3Proceedings of the 1991 XIIth World Congress on Sarcoidosis. Kyoto, Japan, September 8-13, 1991. Sarcoidosis, 1992,9 Suppl 1:1-683.
  • 4Costabel U, Guzman J, Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med, 2001,7: 255-261.
  • 5Marruchella A, Tondini M. Reliability of bronchoalveolar lavage in the routine clinical assessment of patients with sarcoidosis. A retrospective analysis. Panminerva Med, 2002,44:257-260.
  • 6Welker L, Jorres RA, Costabel U, et al. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J, 2004, 24:1000-1006.
  • 7Handa T, Nagai S, Shigematsu M, et al. Patient characteristics and clinical features of Japanese sarcoidosis patients with low bronchoalveolar lavage CDJCDs ratios. Sarcoidosis Vasc Diffuse Lung Dis, 2005,22 : 154-160.
  • 8Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem, 1993,39 : 561-577.
  • 9McGrath DS, Foley PJ, Petrek M, et al. Ace gene I/D polymorphism and sarcoidosis pulmonary disease severity. Am J Respir Crit Care Med, 2001, 164:197-201.
  • 10Niimi T, Tomita H, Sato S, et al. Bronchial responsiveness and angiotensin-converting enzyme gene polymorphism in sarcoidosis patients. Chest, 1998,114:495-499.

同被引文献25

  • 1结节病诊断及治疗方案(第三次修订稿草案)[J].中华结核和呼吸杂志,1994,17(1):9-10. 被引量:149
  • 2Morgenthau AS,Iannuzzi MC.Recent advances in sarcoidosis[J].Chest,2011,139:174-182.
  • 3Grunewald J,Eklund A.Role of CD+4 T cells in sarcoidosis[J].Proc Am Thorac Soc,2007,15:461-464.
  • 4Agostini C,Trentin L,Zambello R,et al.CD8 alveolitis in sarcoidosis:incidence,phenotypic characteristics,and clinical features[J].Am J Med,1993,95:466-472.
  • 5Welker L,Jorres RA,Costabel U,et al.Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases[J].Eur Respir J,2004,24:1000-1006.
  • 6Drent M,Mulder PGH,Wagenaar S,et al.Differences in BAL fluid variables in interstitial lung diseases evaluated by discriminant analysis[J].Eur Respir J,1993,6:803-810.
  • 7Danila E,Jurgauskiene L,Norkuniene J,et al.BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity[J].Ups J Med Sci,2009,114:26-31.
  • 8Cueppens JL,Lacquet LM,Marien G,et al.Alveolar T-cell subsets in pulmonary sarcoidosis:correlation with disease activand effect of steroid treatment[J].Am Rev Respir Dis,1984,129:563-568.
  • 9Danila E,Norkūniene J,Jurgauskiene L,et al.Diagnostic role of BAL fluid CD4/CD8 ratio in different radiographic and clinical forms of pulmonary sarcoidosis[J].Clin Respir J,2009,3:214-221.
  • 10Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med, 2007, 357:2153-2165.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部